Ticker
JNJ

Price
151.05
Stock movement down
-2.84 (-1.85%)
Company name
Johnson & Johnson
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-General
Markedsverdi
394.92B
Ent verdi
484.09B
Pris/omsetning
4.11
Pris/bok
5.29
Utbytte avkastning
2.99%
Utbytte vekst
6.03%
Vekst år
58
FCF-utbetaling
119.38%
Etterfølgende P/E
20.61
Fremtidig P/E
14.57
PEG
3.22
EPS-vekst
-0.30%
1 års avkastning
-14.09%
3 års avkastning
8.01%
5 års avkastning
2.86%
10 års avkastning
6.72%
Sist oppdatert: 2023-03-22
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
29. mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
29. mars 2023

iO Charts is a Seeking Alpha partner

FORRETNINGSINNSIKT

Segment Revenues ($M)

Loading...
Operations comments

In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission

The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021

Geographic Revenues ($M)

Loading...

UTBYTTE

Utbytte – 5 år

Loading...
Data om utbytte
Utbytte per aksje4.52
Utbytte2.99%
UtbetalingsfrekvensKvartalsvis
Maksimal avkastning3.64%
Gjennomsnittlig avkastning2.69%
Minimum avkastning2.36%
Rabatt til gjennomsnittlig avkastning10.12%
Oppsidepotensial11.26%
Avkastning som % av maks avkastning82.32%

Avkastningsfordeling (invers persentil) – 5 år

Loading...
Avkastning distribusjonsdata
Utbytte2.99%
Nåværende avkastningsfordeling1.67%
Avkastning ved 100% (Min.)2.36%
Avkastning ved 90 %2.50%
Avkastning ved 80 %2.55%
Avkastning ved 50 % (median)2.68%
Avkastning ved 20 %2.82%
Avkastning ved 10 %2.91%
Avkastning ved 0 % (maks)3.64%

Utbytte per aksje

Loading...
Utbytte per aksje-data
År med vekst58 years
CCC-statusDividend Champion
Utbytte per aksje4.52
UtbetalingsfrekvensKvartalsvis
Ex-div dato17 Feb 2023
EPS (TTM)7.20
EPS (1 år fremover)10.37
EPS-vekst (5 år)-0.30%
EPS-vekst (5 år fremover)6.40%

Utbyttevekst

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Data om vekst i utbytte
JNJS&P500
DGR MR6.60%-15.45%
DGR TTM6.60%11.27%
DGR 3 år5.87%4.00%
DGR 5 år6.03%5.65%
DGR 10 år6.37%7.37%
DGR 15 år6.97%5.83%
Tid siden forrige endring annonsert347 days
EPS-vekst (5 år)-0.30%
EPS-vekst (5 år fremover)6.40%

Utbetalingsforhold

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Utbetalingsforhold-data
EPS-dekningFCF-dekning
TTM60.13%119.38%
Gjennomsnitt--
Fremover43.59%-
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
23. mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
23. mars 2023

iO Charts is a Seeking Alpha partner

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E20.61
Pris til OCF18.30
Pris til FCF40.93
Pris til EBITDA26.82
EV i forhold til EBITDA32.88

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning4.11
Pris til bok5.29
EV i forhold til salg5.04
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
22. mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
21. mars 2023

iO Charts is a Seeking Alpha partner

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall2.61B
EPS (TTM)7.20
FCF per aksje (TTM)3.63

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)96.04B
Bruttofortjeneste (TTM)64.76B
Driftsinntekter (TTM)23.40B
Netto inntekt (TTM)19.16B
EPS (TTM)7.20
EPS (1 år fremover)10.37

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)67.43%
Driftsmargin (TTM)24.36%
Fortjenestemargin (TTM)19.95%

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter11.36B
Netto fordringer15.89B
Samlede omløpsmidler65.24B
Goodwill33.38B
Immaterielle eiendeler40.34B
Eiendom, anlegg og utstyr46.68B
Sum eiendeler175.12B
Leverandørgjeld10.15B
Kortsiktig/nåværende langsiktig gjeld32.03B
Sum kortsiktig gjeld45.54B
Sum gjeld100.53B
Aksjonærenes egenkapital74.60B
Netto varige driftsmidler-217.00M

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)21.58B
Kapitalutgifter (TTM)3.84B
Fri kontantstrøm (TTM)9.65B
Utbetalt utbytte (TTM)11.52B

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning25.68%
Avkastning på eiendeler10.94%
Avkastning på investert kapital17.97%
Kontantavkastning på investert kapital9.05%
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
19. mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
15. mars 2023

iO Charts is a Seeking Alpha partner

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning153.85
Daglig høy154.06
Daglig lav151.03
Daglig volum7.93M
Tidenes høyeste186.01
1 år analytikerestimat185.05
Beta0.57
EPS (TTM)7.20
Utbytte per aksje4.52
Ex-div dato17 Feb 2023
Neste dato for resultatpresentasjon18 Apr 2023

Nedsidepotensial

Loading...
Nedsidepotensial-data
JNJS&P500
Nåværende prisfall fra toppnotering-18.79%-17.92%
Høyeste prisfall-38.78%-56.47%
Dato for høyeste fall11 Aug 19939 Mar 2009
Gj.snittlig fall fra topp-9.41%-11.51%
Gj.snittlig tid til ny topp19 days13 days
Maks tid til ny topp1038 days1805 days
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
15. mars 2023

iO Charts is a Seeking Alpha partner

Johnson & Johnson (NYSE:NYSE:JNJ) Barclays Global Healthcare Conference March 14, 2023 10:15 AM ETCompany ParticipantsAldo Denti - Company Group Chairman, DePuy Synthes The Orthopedic...
14. mars 2023

iO Charts is a Seeking Alpha partner

SELSKAPSOPPLYSNINGER
JNJ (Johnson & Johnson) company logo
Markedsverdi
394.92B
Markedsverdi kategori
Large-cap
Beskrivelse
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Ansatte
141700
SEC-innsendelser
Adm. direktør
Alex Gorsky
Land
USA
By
New Brunswick
Aksjetype
Common stock
CCC-status
Dividend Champion
Utbyttefrekvens
Kvartalsvis
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
13. mars 2023

iO Charts is a Seeking Alpha partner

Johnson & Johnson's business model is as defensive as they come. Click here to read on two superior low-volatility SWAN alternatives to JNJ stock.
10. mars 2023

iO Charts is a Seeking Alpha partner

FORSTÅ VIRKSOMHETEN
Loading...
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
9. mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
8. mars 2023

iO Charts is a Seeking Alpha partner

NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the company's planned Supreme Court appeal to use bankruptcy to resolve tens of t...
31. mars 2023
(Reuters) -A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the company's planned Supreme Court appeal to use bankruptcy to resolv...
31. mars 2023
Johnson & Johnson stock in Q1 declined for nine straight weeks. Is that the selloff that long investors had been waiting for?
31. mars 2023
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
31. mars 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.
31. mars 2023
In this article, we discuss 11 best Dow Jones dividend stocks according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to r...
30. mars 2023
Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the...
29. mars 2023
Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the...
29. mars 2023
Blue chip stocks can be ideal investments to buy and hold for decades. A couple of stocks that have been falling recently and that are near multi-year lows are Johnson & Johnson (NYSE: JNJ) and Home ...
29. mars 2023
Curious about the "dogs of the Dow" in 2023? Here's what's happening in the darkest corner of Wall Street's most exclusive club.
29. mars 2023
Neste side
Get the latest news and real-time alerts from Johnson & Johnson (JNJ) stock at Seeking Alpha.
8. mars 2023

iO Charts is a Seeking Alpha partner

Johnson & Johnson (NYSE:NYSE:JNJ) Cowen 43rd Annual HealthCare Conference March 7, 2023 11:10 AM ETCompany ParticipantsJoe Wolk - EVP and CFOJessica Moore - VP, IRConference Call...
7. mars 2023

iO Charts is a Seeking Alpha partner